Selected cases at high risk of MYC positivity(ki67% > 90%, early relapse or refractory disease, blastoidmorphology, transformation from pre-existing follicular lymphoma) can bereferred to enhanced settings; 90% agreement (two suggestions not to dotesting for HGBCL and BL). The gene discussed is MYC; the disease is Burkitt lymphoma.